nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Niacin—atherosclerosis	0.0997	0.169	CbGbCtD
Cevimeline—CYP2D6—Simvastatin—atherosclerosis	0.0788	0.134	CbGbCtD
Cevimeline—CYP2D6—Pravastatin—atherosclerosis	0.0771	0.131	CbGbCtD
Cevimeline—CYP2D6—Lovastatin—atherosclerosis	0.0771	0.131	CbGbCtD
Cevimeline—CYP3A4—Rosuvastatin—atherosclerosis	0.0539	0.0916	CbGbCtD
Cevimeline—CYP3A4—Ezetimibe—atherosclerosis	0.0539	0.0916	CbGbCtD
Cevimeline—CYP3A4—Simvastatin—atherosclerosis	0.0501	0.0851	CbGbCtD
Cevimeline—CYP3A4—Lovastatin—atherosclerosis	0.0491	0.0833	CbGbCtD
Cevimeline—CYP3A4—Pravastatin—atherosclerosis	0.0491	0.0833	CbGbCtD
Cevimeline—Flatulence—Ezetimibe—atherosclerosis	0.000582	0.00172	CcSEcCtD
Cevimeline—Pharyngitis—Pravastatin—atherosclerosis	0.00058	0.00171	CcSEcCtD
Cevimeline—Chills—Simvastatin—atherosclerosis	0.00058	0.00171	CcSEcCtD
Cevimeline—Muscle spasms—Lovastatin—atherosclerosis	0.000579	0.00171	CcSEcCtD
Cevimeline—Infection—Rosuvastatin—atherosclerosis	0.000576	0.0017	CcSEcCtD
Cevimeline—Visual impairment—Niacin—atherosclerosis	0.000572	0.00169	CcSEcCtD
Cevimeline—Alopecia—Simvastatin—atherosclerosis	0.000572	0.00169	CcSEcCtD
Cevimeline—Back pain—Ezetimibe—atherosclerosis	0.000571	0.00168	CcSEcCtD
Cevimeline—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000568	0.00168	CcSEcCtD
Cevimeline—Muscle spasms—Ezetimibe—atherosclerosis	0.000568	0.00167	CcSEcCtD
Cevimeline—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000568	0.00167	CcSEcCtD
Cevimeline—Tremor—Lovastatin—atherosclerosis	0.000564	0.00166	CcSEcCtD
Cevimeline—Visual impairment—Pravastatin—atherosclerosis	0.000564	0.00166	CcSEcCtD
Cevimeline—Ill-defined disorder—Lovastatin—atherosclerosis	0.000559	0.00165	CcSEcCtD
Cevimeline—Eye disorder—Niacin—atherosclerosis	0.000555	0.00164	CcSEcCtD
Cevimeline—Flatulence—Simvastatin—atherosclerosis	0.000555	0.00164	CcSEcCtD
Cevimeline—Tinnitus—Niacin—atherosclerosis	0.000554	0.00163	CcSEcCtD
Cevimeline—Dysgeusia—Simvastatin—atherosclerosis	0.000551	0.00163	CcSEcCtD
Cevimeline—Flushing—Niacin—atherosclerosis	0.000551	0.00163	CcSEcCtD
Cevimeline—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000548	0.00162	CcSEcCtD
Cevimeline—Anaemia—Ezetimibe—atherosclerosis	0.000546	0.00161	CcSEcCtD
Cevimeline—Tinnitus—Pravastatin—atherosclerosis	0.000545	0.00161	CcSEcCtD
Cevimeline—Malaise—Lovastatin—atherosclerosis	0.000543	0.0016	CcSEcCtD
Cevimeline—Cardiac disorder—Pravastatin—atherosclerosis	0.000543	0.0016	CcSEcCtD
Cevimeline—Flushing—Pravastatin—atherosclerosis	0.000543	0.0016	CcSEcCtD
Cevimeline—Muscle spasms—Simvastatin—atherosclerosis	0.000541	0.0016	CcSEcCtD
Cevimeline—Vertigo—Lovastatin—atherosclerosis	0.000541	0.00159	CcSEcCtD
Cevimeline—Angiopathy—Niacin—atherosclerosis	0.000539	0.00159	CcSEcCtD
Cevimeline—Leukopenia—Lovastatin—atherosclerosis	0.000539	0.00159	CcSEcCtD
Cevimeline—Chills—Niacin—atherosclerosis	0.000533	0.00157	CcSEcCtD
Cevimeline—Malaise—Ezetimibe—atherosclerosis	0.000532	0.00157	CcSEcCtD
Cevimeline—Arrhythmia—Niacin—atherosclerosis	0.000531	0.00156	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000528	0.00156	CcSEcCtD
Cevimeline—Tremor—Simvastatin—atherosclerosis	0.000528	0.00156	CcSEcCtD
Cevimeline—Alopecia—Niacin—atherosclerosis	0.000525	0.00155	CcSEcCtD
Cevimeline—Chills—Pravastatin—atherosclerosis	0.000525	0.00155	CcSEcCtD
Cevimeline—Insomnia—Rosuvastatin—atherosclerosis	0.000524	0.00155	CcSEcCtD
Cevimeline—Ill-defined disorder—Simvastatin—atherosclerosis	0.000522	0.00154	CcSEcCtD
Cevimeline—Arrhythmia—Pravastatin—atherosclerosis	0.000522	0.00154	CcSEcCtD
Cevimeline—Palpitations—Ezetimibe—atherosclerosis	0.000522	0.00154	CcSEcCtD
Cevimeline—Paraesthesia—Rosuvastatin—atherosclerosis	0.000521	0.00153	CcSEcCtD
Cevimeline—Anaemia—Simvastatin—atherosclerosis	0.00052	0.00153	CcSEcCtD
Cevimeline—Malnutrition—Niacin—atherosclerosis	0.000517	0.00152	CcSEcCtD
Cevimeline—Alopecia—Pravastatin—atherosclerosis	0.000517	0.00152	CcSEcCtD
Cevimeline—Cough—Ezetimibe—atherosclerosis	0.000515	0.00152	CcSEcCtD
Cevimeline—Myalgia—Lovastatin—atherosclerosis	0.000512	0.00151	CcSEcCtD
Cevimeline—Chest pain—Lovastatin—atherosclerosis	0.000512	0.00151	CcSEcCtD
Cevimeline—Arthralgia—Lovastatin—atherosclerosis	0.000512	0.00151	CcSEcCtD
Cevimeline—Anxiety—Lovastatin—atherosclerosis	0.000511	0.00151	CcSEcCtD
Cevimeline—Dyspepsia—Rosuvastatin—atherosclerosis	0.00051	0.0015	CcSEcCtD
Cevimeline—Hypertension—Ezetimibe—atherosclerosis	0.00051	0.0015	CcSEcCtD
Cevimeline—Flatulence—Niacin—atherosclerosis	0.000509	0.0015	CcSEcCtD
Cevimeline—Malaise—Simvastatin—atherosclerosis	0.000508	0.0015	CcSEcCtD
Cevimeline—Discomfort—Lovastatin—atherosclerosis	0.000506	0.00149	CcSEcCtD
Cevimeline—Vertigo—Simvastatin—atherosclerosis	0.000506	0.00149	CcSEcCtD
Cevimeline—Leukopenia—Simvastatin—atherosclerosis	0.000504	0.00149	CcSEcCtD
Cevimeline—Myalgia—Ezetimibe—atherosclerosis	0.000503	0.00148	CcSEcCtD
Cevimeline—Arthralgia—Ezetimibe—atherosclerosis	0.000503	0.00148	CcSEcCtD
Cevimeline—Chest pain—Ezetimibe—atherosclerosis	0.000503	0.00148	CcSEcCtD
Cevimeline—Flatulence—Pravastatin—atherosclerosis	0.000502	0.00148	CcSEcCtD
Cevimeline—Dysgeusia—Pravastatin—atherosclerosis	0.000498	0.00147	CcSEcCtD
Cevimeline—Muscle spasms—Niacin—atherosclerosis	0.000497	0.00147	CcSEcCtD
Cevimeline—Discomfort—Ezetimibe—atherosclerosis	0.000497	0.00146	CcSEcCtD
Cevimeline—Pain—Rosuvastatin—atherosclerosis	0.000496	0.00146	CcSEcCtD
Cevimeline—Constipation—Rosuvastatin—atherosclerosis	0.000496	0.00146	CcSEcCtD
Cevimeline—Confusional state—Lovastatin—atherosclerosis	0.000495	0.00146	CcSEcCtD
Cevimeline—Muscle spasms—Pravastatin—atherosclerosis	0.000489	0.00144	CcSEcCtD
Cevimeline—Infection—Lovastatin—atherosclerosis	0.000488	0.00144	CcSEcCtD
Cevimeline—Confusional state—Ezetimibe—atherosclerosis	0.000486	0.00143	CcSEcCtD
Cevimeline—Thrombocytopenia—Lovastatin—atherosclerosis	0.000481	0.00142	CcSEcCtD
Cevimeline—Arthralgia—Simvastatin—atherosclerosis	0.000479	0.00141	CcSEcCtD
Cevimeline—Chest pain—Simvastatin—atherosclerosis	0.000479	0.00141	CcSEcCtD
Cevimeline—Myalgia—Simvastatin—atherosclerosis	0.000479	0.00141	CcSEcCtD
Cevimeline—Infection—Ezetimibe—atherosclerosis	0.000479	0.00141	CcSEcCtD
Cevimeline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000478	0.00141	CcSEcCtD
Cevimeline—Anxiety—Simvastatin—atherosclerosis	0.000478	0.00141	CcSEcCtD
Cevimeline—Tremor—Pravastatin—atherosclerosis	0.000477	0.00141	CcSEcCtD
Cevimeline—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000474	0.0014	CcSEcCtD
Cevimeline—Discomfort—Simvastatin—atherosclerosis	0.000474	0.0014	CcSEcCtD
Cevimeline—Nervous system disorder—Ezetimibe—atherosclerosis	0.000473	0.00139	CcSEcCtD
Cevimeline—Ill-defined disorder—Pravastatin—atherosclerosis	0.000472	0.00139	CcSEcCtD
Cevimeline—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000472	0.00139	CcSEcCtD
Cevimeline—Anaemia—Pravastatin—atherosclerosis	0.00047	0.00139	CcSEcCtD
Cevimeline—Anorexia—Lovastatin—atherosclerosis	0.000468	0.00138	CcSEcCtD
Cevimeline—Skin disorder—Ezetimibe—atherosclerosis	0.000468	0.00138	CcSEcCtD
Cevimeline—Vertigo—Niacin—atherosclerosis	0.000464	0.00137	CcSEcCtD
Cevimeline—Syncope—Niacin—atherosclerosis	0.000464	0.00137	CcSEcCtD
Cevimeline—Confusional state—Simvastatin—atherosclerosis	0.000463	0.00137	CcSEcCtD
Cevimeline—Leukopenia—Niacin—atherosclerosis	0.000463	0.00136	CcSEcCtD
Cevimeline—Urticaria—Rosuvastatin—atherosclerosis	0.000461	0.00136	CcSEcCtD
Cevimeline—Oedema—Simvastatin—atherosclerosis	0.00046	0.00135	CcSEcCtD
Cevimeline—Malaise—Pravastatin—atherosclerosis	0.000459	0.00135	CcSEcCtD
Cevimeline—Abdominal pain—Rosuvastatin—atherosclerosis	0.000458	0.00135	CcSEcCtD
Cevimeline—Vertigo—Pravastatin—atherosclerosis	0.000457	0.00135	CcSEcCtD
Cevimeline—Palpitations—Niacin—atherosclerosis	0.000457	0.00135	CcSEcCtD
Cevimeline—Infection—Simvastatin—atherosclerosis	0.000457	0.00135	CcSEcCtD
Cevimeline—Leukopenia—Pravastatin—atherosclerosis	0.000456	0.00134	CcSEcCtD
Cevimeline—Loss of consciousness—Niacin—atherosclerosis	0.000454	0.00134	CcSEcCtD
Cevimeline—Cough—Niacin—atherosclerosis	0.000451	0.00133	CcSEcCtD
Cevimeline—Thrombocytopenia—Simvastatin—atherosclerosis	0.00045	0.00133	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000448	0.00132	CcSEcCtD
Cevimeline—Insomnia—Lovastatin—atherosclerosis	0.000444	0.00131	CcSEcCtD
Cevimeline—Cough—Pravastatin—atherosclerosis	0.000444	0.00131	CcSEcCtD
Cevimeline—Paraesthesia—Lovastatin—atherosclerosis	0.000441	0.0013	CcSEcCtD
Cevimeline—Arthralgia—Niacin—atherosclerosis	0.00044	0.0013	CcSEcCtD
Cevimeline—Myalgia—Niacin—atherosclerosis	0.00044	0.0013	CcSEcCtD
Cevimeline—Hypertension—Pravastatin—atherosclerosis	0.000439	0.0013	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000439	0.00129	CcSEcCtD
Cevimeline—Anorexia—Simvastatin—atherosclerosis	0.000438	0.00129	CcSEcCtD
Cevimeline—Dyspnoea—Lovastatin—atherosclerosis	0.000438	0.00129	CcSEcCtD
Cevimeline—Insomnia—Ezetimibe—atherosclerosis	0.000436	0.00128	CcSEcCtD
Cevimeline—Chest pain—Pravastatin—atherosclerosis	0.000433	0.00128	CcSEcCtD
Cevimeline—Arthralgia—Pravastatin—atherosclerosis	0.000433	0.00128	CcSEcCtD
Cevimeline—Myalgia—Pravastatin—atherosclerosis	0.000433	0.00128	CcSEcCtD
Cevimeline—Paraesthesia—Ezetimibe—atherosclerosis	0.000433	0.00128	CcSEcCtD
Cevimeline—Dyspepsia—Lovastatin—atherosclerosis	0.000432	0.00128	CcSEcCtD
Cevimeline—Anxiety—Pravastatin—atherosclerosis	0.000432	0.00127	CcSEcCtD
Cevimeline—Dyspnoea—Ezetimibe—atherosclerosis	0.00043	0.00127	CcSEcCtD
Cevimeline—Discomfort—Pravastatin—atherosclerosis	0.000428	0.00126	CcSEcCtD
Cevimeline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000427	0.00126	CcSEcCtD
Cevimeline—Decreased appetite—Lovastatin—atherosclerosis	0.000427	0.00126	CcSEcCtD
Cevimeline—Dyspepsia—Ezetimibe—atherosclerosis	0.000424	0.00125	CcSEcCtD
Cevimeline—Fatigue—Lovastatin—atherosclerosis	0.000424	0.00125	CcSEcCtD
Cevimeline—Oedema—Niacin—atherosclerosis	0.000422	0.00124	CcSEcCtD
Cevimeline—Constipation—Lovastatin—atherosclerosis	0.00042	0.00124	CcSEcCtD
Cevimeline—Pain—Lovastatin—atherosclerosis	0.00042	0.00124	CcSEcCtD
Cevimeline—Confusional state—Pravastatin—atherosclerosis	0.000419	0.00124	CcSEcCtD
Cevimeline—Decreased appetite—Ezetimibe—atherosclerosis	0.000419	0.00123	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000419	0.00123	CcSEcCtD
Cevimeline—Asthenia—Rosuvastatin—atherosclerosis	0.000416	0.00123	CcSEcCtD
Cevimeline—Insomnia—Simvastatin—atherosclerosis	0.000416	0.00123	CcSEcCtD
Cevimeline—Oedema—Pravastatin—atherosclerosis	0.000415	0.00122	CcSEcCtD
Cevimeline—Fatigue—Ezetimibe—atherosclerosis	0.000415	0.00122	CcSEcCtD
Cevimeline—Shock—Niacin—atherosclerosis	0.000415	0.00122	CcSEcCtD
Cevimeline—Infection—Pravastatin—atherosclerosis	0.000413	0.00122	CcSEcCtD
Cevimeline—Paraesthesia—Simvastatin—atherosclerosis	0.000413	0.00122	CcSEcCtD
Cevimeline—Pain—Ezetimibe—atherosclerosis	0.000412	0.00121	CcSEcCtD
Cevimeline—Constipation—Ezetimibe—atherosclerosis	0.000412	0.00121	CcSEcCtD
Cevimeline—Tachycardia—Niacin—atherosclerosis	0.000412	0.00121	CcSEcCtD
Cevimeline—Pruritus—Rosuvastatin—atherosclerosis	0.00041	0.00121	CcSEcCtD
Cevimeline—Skin disorder—Niacin—atherosclerosis	0.00041	0.00121	CcSEcCtD
Cevimeline—Dyspnoea—Simvastatin—atherosclerosis	0.00041	0.00121	CcSEcCtD
Cevimeline—Hyperhidrosis—Niacin—atherosclerosis	0.000408	0.0012	CcSEcCtD
Cevimeline—Thrombocytopenia—Pravastatin—atherosclerosis	0.000407	0.0012	CcSEcCtD
Cevimeline—Feeling abnormal—Lovastatin—atherosclerosis	0.000405	0.00119	CcSEcCtD
Cevimeline—Dyspepsia—Simvastatin—atherosclerosis	0.000404	0.00119	CcSEcCtD
Cevimeline—Anorexia—Niacin—atherosclerosis	0.000402	0.00119	CcSEcCtD
Cevimeline—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000402	0.00118	CcSEcCtD
Cevimeline—Hyperhidrosis—Pravastatin—atherosclerosis	0.000402	0.00118	CcSEcCtD
Cevimeline—Decreased appetite—Simvastatin—atherosclerosis	0.000399	0.00118	CcSEcCtD
Cevimeline—Feeling abnormal—Ezetimibe—atherosclerosis	0.000397	0.00117	CcSEcCtD
Cevimeline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000397	0.00117	CcSEcCtD
Cevimeline—Fatigue—Simvastatin—atherosclerosis	0.000396	0.00117	CcSEcCtD
Cevimeline—Anorexia—Pravastatin—atherosclerosis	0.000396	0.00117	CcSEcCtD
Cevimeline—Hypotension—Niacin—atherosclerosis	0.000394	0.00116	CcSEcCtD
Cevimeline—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000394	0.00116	CcSEcCtD
Cevimeline—Pain—Simvastatin—atherosclerosis	0.000393	0.00116	CcSEcCtD
Cevimeline—Constipation—Simvastatin—atherosclerosis	0.000393	0.00116	CcSEcCtD
Cevimeline—Urticaria—Lovastatin—atherosclerosis	0.00039	0.00115	CcSEcCtD
Cevimeline—Abdominal pain—Lovastatin—atherosclerosis	0.000388	0.00115	CcSEcCtD
Cevimeline—Body temperature increased—Lovastatin—atherosclerosis	0.000388	0.00115	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000384	0.00113	CcSEcCtD
Cevimeline—Dizziness—Rosuvastatin—atherosclerosis	0.000383	0.00113	CcSEcCtD
Cevimeline—Urticaria—Ezetimibe—atherosclerosis	0.000383	0.00113	CcSEcCtD
Cevimeline—Insomnia—Niacin—atherosclerosis	0.000382	0.00113	CcSEcCtD
Cevimeline—Abdominal pain—Ezetimibe—atherosclerosis	0.000381	0.00112	CcSEcCtD
Cevimeline—Body temperature increased—Ezetimibe—atherosclerosis	0.000381	0.00112	CcSEcCtD
Cevimeline—Paraesthesia—Niacin—atherosclerosis	0.000379	0.00112	CcSEcCtD
Cevimeline—Feeling abnormal—Simvastatin—atherosclerosis	0.000379	0.00112	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000378	0.00112	CcSEcCtD
Cevimeline—Dyspnoea—Niacin—atherosclerosis	0.000376	0.00111	CcSEcCtD
Cevimeline—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000376	0.00111	CcSEcCtD
Cevimeline—Insomnia—Pravastatin—atherosclerosis	0.000376	0.00111	CcSEcCtD
Cevimeline—Somnolence—Niacin—atherosclerosis	0.000375	0.00111	CcSEcCtD
Cevimeline—Paraesthesia—Pravastatin—atherosclerosis	0.000373	0.0011	CcSEcCtD
Cevimeline—Dyspepsia—Niacin—atherosclerosis	0.000371	0.0011	CcSEcCtD
Cevimeline—Dyspnoea—Pravastatin—atherosclerosis	0.00037	0.00109	CcSEcCtD
Cevimeline—Decreased appetite—Niacin—atherosclerosis	0.000367	0.00108	CcSEcCtD
Cevimeline—Dyspepsia—Pravastatin—atherosclerosis	0.000366	0.00108	CcSEcCtD
Cevimeline—Rash—Rosuvastatin—atherosclerosis	0.000366	0.00108	CcSEcCtD
Cevimeline—Dermatitis—Rosuvastatin—atherosclerosis	0.000365	0.00108	CcSEcCtD
Cevimeline—Urticaria—Simvastatin—atherosclerosis	0.000365	0.00108	CcSEcCtD
Cevimeline—Abdominal pain—Simvastatin—atherosclerosis	0.000363	0.00107	CcSEcCtD
Cevimeline—Body temperature increased—Simvastatin—atherosclerosis	0.000363	0.00107	CcSEcCtD
Cevimeline—Headache—Rosuvastatin—atherosclerosis	0.000363	0.00107	CcSEcCtD
Cevimeline—Hypersensitivity—Lovastatin—atherosclerosis	0.000362	0.00107	CcSEcCtD
Cevimeline—Decreased appetite—Pravastatin—atherosclerosis	0.000361	0.00106	CcSEcCtD
Cevimeline—Pain—Niacin—atherosclerosis	0.000361	0.00106	CcSEcCtD
Cevimeline—Fatigue—Pravastatin—atherosclerosis	0.000358	0.00106	CcSEcCtD
Cevimeline—Pain—Pravastatin—atherosclerosis	0.000355	0.00105	CcSEcCtD
Cevimeline—Constipation—Pravastatin—atherosclerosis	0.000355	0.00105	CcSEcCtD
Cevimeline—Hypersensitivity—Ezetimibe—atherosclerosis	0.000355	0.00105	CcSEcCtD
Cevimeline—Asthenia—Lovastatin—atherosclerosis	0.000352	0.00104	CcSEcCtD
Cevimeline—Pruritus—Lovastatin—atherosclerosis	0.000348	0.00102	CcSEcCtD
Cevimeline—Asthenia—Ezetimibe—atherosclerosis	0.000346	0.00102	CcSEcCtD
Cevimeline—Gastrointestinal pain—Niacin—atherosclerosis	0.000345	0.00102	CcSEcCtD
Cevimeline—Nausea—Rosuvastatin—atherosclerosis	0.000344	0.00102	CcSEcCtD
Cevimeline—Feeling abnormal—Pravastatin—atherosclerosis	0.000342	0.00101	CcSEcCtD
Cevimeline—Pruritus—Ezetimibe—atherosclerosis	0.000341	0.00101	CcSEcCtD
Cevimeline—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00034	0.001	CcSEcCtD
Cevimeline—Hypersensitivity—Simvastatin—atherosclerosis	0.000339	0.000998	CcSEcCtD
Cevimeline—Diarrhoea—Lovastatin—atherosclerosis	0.000336	0.000991	CcSEcCtD
Cevimeline—Urticaria—Niacin—atherosclerosis	0.000335	0.000988	CcSEcCtD
Cevimeline—Abdominal pain—Niacin—atherosclerosis	0.000334	0.000983	CcSEcCtD
Cevimeline—Body temperature increased—Niacin—atherosclerosis	0.000334	0.000983	CcSEcCtD
Cevimeline—Urticaria—Pravastatin—atherosclerosis	0.00033	0.000973	CcSEcCtD
Cevimeline—Asthenia—Simvastatin—atherosclerosis	0.00033	0.000972	CcSEcCtD
Cevimeline—Diarrhoea—Ezetimibe—atherosclerosis	0.00033	0.000972	CcSEcCtD
Cevimeline—Abdominal pain—Pravastatin—atherosclerosis	0.000328	0.000968	CcSEcCtD
Cevimeline—Body temperature increased—Pravastatin—atherosclerosis	0.000328	0.000968	CcSEcCtD
Cevimeline—Pruritus—Simvastatin—atherosclerosis	0.000325	0.000959	CcSEcCtD
Cevimeline—Dizziness—Lovastatin—atherosclerosis	0.000325	0.000958	CcSEcCtD
Cevimeline—Dizziness—Ezetimibe—atherosclerosis	0.000319	0.000939	CcSEcCtD
Cevimeline—Diarrhoea—Simvastatin—atherosclerosis	0.000314	0.000927	CcSEcCtD
Cevimeline—Vomiting—Lovastatin—atherosclerosis	0.000312	0.000921	CcSEcCtD
Cevimeline—Hypersensitivity—Niacin—atherosclerosis	0.000311	0.000917	CcSEcCtD
Cevimeline—Rash—Lovastatin—atherosclerosis	0.00031	0.000913	CcSEcCtD
Cevimeline—Dermatitis—Lovastatin—atherosclerosis	0.000309	0.000912	CcSEcCtD
Cevimeline—Headache—Lovastatin—atherosclerosis	0.000308	0.000907	CcSEcCtD
Cevimeline—Vomiting—Ezetimibe—atherosclerosis	0.000306	0.000903	CcSEcCtD
Cevimeline—Hypersensitivity—Pravastatin—atherosclerosis	0.000306	0.000902	CcSEcCtD
Cevimeline—Dizziness—Simvastatin—atherosclerosis	0.000304	0.000896	CcSEcCtD
Cevimeline—Rash—Ezetimibe—atherosclerosis	0.000304	0.000896	CcSEcCtD
Cevimeline—Dermatitis—Ezetimibe—atherosclerosis	0.000304	0.000895	CcSEcCtD
Cevimeline—Asthenia—Niacin—atherosclerosis	0.000303	0.000893	CcSEcCtD
Cevimeline—Headache—Ezetimibe—atherosclerosis	0.000302	0.00089	CcSEcCtD
Cevimeline—Pruritus—Niacin—atherosclerosis	0.000299	0.00088	CcSEcCtD
Cevimeline—Asthenia—Pravastatin—atherosclerosis	0.000298	0.000879	CcSEcCtD
Cevimeline—Pruritus—Pravastatin—atherosclerosis	0.000294	0.000867	CcSEcCtD
Cevimeline—Vomiting—Simvastatin—atherosclerosis	0.000292	0.000861	CcSEcCtD
Cevimeline—Nausea—Lovastatin—atherosclerosis	0.000292	0.00086	CcSEcCtD
Cevimeline—Rash—Simvastatin—atherosclerosis	0.00029	0.000854	CcSEcCtD
Cevimeline—Dermatitis—Simvastatin—atherosclerosis	0.000289	0.000853	CcSEcCtD
Cevimeline—Diarrhoea—Niacin—atherosclerosis	0.000289	0.000851	CcSEcCtD
Cevimeline—Headache—Simvastatin—atherosclerosis	0.000288	0.000849	CcSEcCtD
Cevimeline—Nausea—Ezetimibe—atherosclerosis	0.000286	0.000844	CcSEcCtD
Cevimeline—Diarrhoea—Pravastatin—atherosclerosis	0.000284	0.000838	CcSEcCtD
Cevimeline—Dizziness—Niacin—atherosclerosis	0.000279	0.000823	CcSEcCtD
Cevimeline—Dizziness—Pravastatin—atherosclerosis	0.000275	0.00081	CcSEcCtD
Cevimeline—Nausea—Simvastatin—atherosclerosis	0.000273	0.000805	CcSEcCtD
Cevimeline—Vomiting—Niacin—atherosclerosis	0.000268	0.000791	CcSEcCtD
Cevimeline—Rash—Niacin—atherosclerosis	0.000266	0.000784	CcSEcCtD
Cevimeline—Dermatitis—Niacin—atherosclerosis	0.000266	0.000784	CcSEcCtD
Cevimeline—Headache—Niacin—atherosclerosis	0.000264	0.000779	CcSEcCtD
Cevimeline—Vomiting—Pravastatin—atherosclerosis	0.000264	0.000779	CcSEcCtD
Cevimeline—Rash—Pravastatin—atherosclerosis	0.000262	0.000772	CcSEcCtD
Cevimeline—Dermatitis—Pravastatin—atherosclerosis	0.000262	0.000772	CcSEcCtD
Cevimeline—Headache—Pravastatin—atherosclerosis	0.00026	0.000767	CcSEcCtD
Cevimeline—Nausea—Niacin—atherosclerosis	0.000251	0.000739	CcSEcCtD
Cevimeline—Nausea—Pravastatin—atherosclerosis	0.000247	0.000728	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	3.54e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	3.53e-05	0.000491	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CETP—atherosclerosis	3.5e-05	0.000487	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLTP—atherosclerosis	3.44e-05	0.000478	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CNR2—atherosclerosis	3.41e-05	0.000475	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	3.41e-05	0.000474	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	3.41e-05	0.000474	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CNR2—atherosclerosis	3.4e-05	0.000473	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	3.4e-05	0.000473	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	3.4e-05	0.000473	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	3.4e-05	0.000472	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	3.39e-05	0.000471	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FABP4—atherosclerosis	3.39e-05	0.000471	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LCAT—atherosclerosis	3.39e-05	0.000471	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	3.37e-05	0.000468	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	3.36e-05	0.000466	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SCARB1—atherosclerosis	3.35e-05	0.000466	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA4—atherosclerosis	3.33e-05	0.000462	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.27e-05	0.000454	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	3.24e-05	0.00045	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	3.23e-05	0.000449	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	3.22e-05	0.000447	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	3.2e-05	0.000445	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMGCR—atherosclerosis	3.17e-05	0.00044	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	3.06e-05	0.000425	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	3.05e-05	0.000424	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VWF—atherosclerosis	3.04e-05	0.000423	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VWF—atherosclerosis	3.03e-05	0.000422	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOC3—atherosclerosis	3.02e-05	0.00042	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.02e-05	0.00042	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOC3—atherosclerosis	3.01e-05	0.000419	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LDLR—atherosclerosis	3.01e-05	0.000418	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LDLR—atherosclerosis	3e-05	0.000417	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.98e-05	0.000414	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.98e-05	0.000414	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	2.96e-05	0.000412	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	2.95e-05	0.00041	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL3—atherosclerosis	2.94e-05	0.000408	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL3—atherosclerosis	2.93e-05	0.000407	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.86e-05	0.000398	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.86e-05	0.000398	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.86e-05	0.000398	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA2—atherosclerosis	2.86e-05	0.000398	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.83e-05	0.000393	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCA1—atherosclerosis	2.82e-05	0.000392	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NCF1—atherosclerosis	2.81e-05	0.000391	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NCF1—atherosclerosis	2.8e-05	0.00039	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—F2—atherosclerosis	2.74e-05	0.00038	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPA—atherosclerosis	2.73e-05	0.00038	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—F2—atherosclerosis	2.73e-05	0.000379	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AGT—atherosclerosis	2.69e-05	0.000374	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AGT—atherosclerosis	2.68e-05	0.000373	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR2—atherosclerosis	2.66e-05	0.000369	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	2.66e-05	0.000369	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR2—atherosclerosis	2.65e-05	0.000368	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	2.65e-05	0.000368	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BGN—atherosclerosis	2.64e-05	0.000368	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CYBA—atherosclerosis	2.64e-05	0.000367	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CYBA—atherosclerosis	2.64e-05	0.000366	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.62e-05	0.000364	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA5—atherosclerosis	2.62e-05	0.000364	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	2.61e-05	0.000363	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GHRL—atherosclerosis	2.59e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PARP1—atherosclerosis	2.59e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLAT—atherosclerosis	2.59e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PARP1—atherosclerosis	2.58e-05	0.000359	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLAT—atherosclerosis	2.58e-05	0.000359	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GHRL—atherosclerosis	2.58e-05	0.000359	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—atherosclerosis	2.57e-05	0.000357	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.52e-05	0.00035	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—F2—atherosclerosis	2.49e-05	0.000345	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—F2—atherosclerosis	2.48e-05	0.000344	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.43e-05	0.000338	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—atherosclerosis	2.42e-05	0.000336	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	2.38e-05	0.000331	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	2.37e-05	0.00033	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.36e-05	0.000327	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOB—atherosclerosis	2.32e-05	0.000322	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KNG1—atherosclerosis	2.27e-05	0.000316	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KNG1—atherosclerosis	2.26e-05	0.000315	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	2.26e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—atherosclerosis	2.26e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	2.25e-05	0.000313	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	2.22e-05	0.000308	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LCAT—atherosclerosis	2.21e-05	0.000308	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FABP4—atherosclerosis	2.21e-05	0.000308	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LPL—atherosclerosis	2.21e-05	0.000308	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	2.21e-05	0.000307	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLG—atherosclerosis	2.2e-05	0.000306	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLG—atherosclerosis	2.19e-05	0.000305	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.18e-05	0.000303	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA4—atherosclerosis	2.17e-05	0.000302	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LIPC—atherosclerosis	2.17e-05	0.000302	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GPX1—atherosclerosis	2.16e-05	0.0003	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOC3—atherosclerosis	2.16e-05	0.0003	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LDLR—atherosclerosis	2.14e-05	0.000298	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.14e-05	0.000297	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CD36—atherosclerosis	2.1e-05	0.000292	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CETP—atherosclerosis	2.09e-05	0.000291	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	2.08e-05	0.00029	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	2.08e-05	0.000289	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP3—atherosclerosis	2.01e-05	0.00028	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP3—atherosclerosis	2.01e-05	0.000279	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SCARB1—atherosclerosis	2e-05	0.000279	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—atherosclerosis	2e-05	0.000278	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—atherosclerosis	2e-05	0.000278	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—atherosclerosis	1.99e-05	0.000277	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.97e-05	0.000274	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARA—atherosclerosis	1.96e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOB—atherosclerosis	1.94e-05	0.00027	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOB—atherosclerosis	1.94e-05	0.000269	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.93e-05	0.000268	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	1.92e-05	0.000267	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—atherosclerosis	1.91e-05	0.000266	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—atherosclerosis	1.91e-05	0.000265	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL5—atherosclerosis	1.9e-05	0.000264	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AGT—atherosclerosis	1.89e-05	0.000263	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL5—atherosclerosis	1.89e-05	0.000263	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.89e-05	0.000263	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.87e-05	0.00026	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.87e-05	0.00026	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.87e-05	0.00026	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA2—atherosclerosis	1.87e-05	0.00026	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LPL—atherosclerosis	1.86e-05	0.000258	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—atherosclerosis	1.86e-05	0.000258	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LPL—atherosclerosis	1.85e-05	0.000257	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.85e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—atherosclerosis	1.84e-05	0.000256	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA1—atherosclerosis	1.83e-05	0.000255	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	1.81e-05	0.000251	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	1.8e-05	0.00025	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPA—atherosclerosis	1.79e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SPP1—atherosclerosis	1.76e-05	0.000244	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SPP1—atherosclerosis	1.75e-05	0.000244	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.75e-05	0.000243	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	1.75e-05	0.000243	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BGN—atherosclerosis	1.73e-05	0.00024	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA5—atherosclerosis	1.71e-05	0.000238	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.69e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CG—atherosclerosis	1.67e-05	0.000233	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.65e-05	0.000229	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	1.63e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	1.62e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—atherosclerosis	1.62e-05	0.000225	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.59e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGT—atherosclerosis	1.59e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—atherosclerosis	1.59e-05	0.00022	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGT—atherosclerosis	1.58e-05	0.00022	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—atherosclerosis	1.56e-05	0.000216	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—atherosclerosis	1.56e-05	0.000216	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—atherosclerosis	1.55e-05	0.000216	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—atherosclerosis	1.55e-05	0.000216	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—atherosclerosis	1.54e-05	0.000214	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOA1—atherosclerosis	1.54e-05	0.000214	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—atherosclerosis	1.54e-05	0.000214	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOA1—atherosclerosis	1.53e-05	0.000213	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ESR1—atherosclerosis	1.49e-05	0.000207	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ESR1—atherosclerosis	1.48e-05	0.000206	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2—atherosclerosis	1.47e-05	0.000204	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2—atherosclerosis	1.46e-05	0.000203	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—atherosclerosis	1.45e-05	0.000202	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.45e-05	0.000201	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.43e-05	0.000198	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LIPC—atherosclerosis	1.42e-05	0.000197	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOC3—atherosclerosis	1.41e-05	0.000196	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.4e-05	0.000195	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LDLR—atherosclerosis	1.4e-05	0.000195	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	1.4e-05	0.000195	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—atherosclerosis	1.39e-05	0.000193	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOB—atherosclerosis	1.39e-05	0.000193	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CETP—atherosclerosis	1.37e-05	0.00019	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.35e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.35e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	1.34e-05	0.000186	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—atherosclerosis	1.33e-05	0.000185	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—atherosclerosis	1.33e-05	0.000184	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPL—atherosclerosis	1.32e-05	0.000184	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.31e-05	0.000182	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—atherosclerosis	1.31e-05	0.000182	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—atherosclerosis	1.3e-05	0.000181	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GPX1—atherosclerosis	1.29e-05	0.00018	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—atherosclerosis	1.29e-05	0.000179	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—atherosclerosis	1.28e-05	0.000178	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—atherosclerosis	1.27e-05	0.000177	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD36—atherosclerosis	1.26e-05	0.000175	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.24e-05	0.000172	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	1.22e-05	0.00017	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	1.22e-05	0.000169	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.19e-05	0.000166	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARA—atherosclerosis	1.17e-05	0.000163	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—atherosclerosis	1.17e-05	0.000162	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—atherosclerosis	1.16e-05	0.000162	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AGT—atherosclerosis	1.13e-05	0.000157	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—atherosclerosis	1.11e-05	0.000154	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.1e-05	0.000153	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—atherosclerosis	1.1e-05	0.000153	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA1—atherosclerosis	1.1e-05	0.000152	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	1.03e-05	0.000144	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	1.03e-05	0.000143	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	9.99e-06	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	9.96e-06	0.000138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—atherosclerosis	9.84e-06	0.000137	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—atherosclerosis	9.81e-06	0.000136	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—atherosclerosis	9.67e-06	0.000134	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—atherosclerosis	9.48e-06	0.000132	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.46e-06	0.000132	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—atherosclerosis	9.36e-06	0.00013	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—atherosclerosis	9.33e-06	0.00013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	9.26e-06	0.000129	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	9.23e-06	0.000128	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	9.1e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	9.08e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	9.07e-06	0.000126	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOB—atherosclerosis	9.06e-06	0.000126	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	9.05e-06	0.000126	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.82e-06	0.000123	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—atherosclerosis	8.69e-06	0.000121	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPL—atherosclerosis	8.66e-06	0.00012	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX1—atherosclerosis	8.44e-06	0.000117	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	8.4e-06	0.000117	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	8.38e-06	0.000116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—atherosclerosis	8.32e-06	0.000116	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—atherosclerosis	8.31e-06	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—atherosclerosis	8.29e-06	0.000115	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD36—atherosclerosis	8.22e-06	0.000114	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	7.95e-06	0.00011	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	7.92e-06	0.00011	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.79e-06	0.000108	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	7.71e-06	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	7.69e-06	0.000107	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARA—atherosclerosis	7.65e-06	0.000106	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—atherosclerosis	7.6e-06	0.000106	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AGT—atherosclerosis	7.4e-06	0.000103	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—atherosclerosis	7.25e-06	0.000101	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—atherosclerosis	7.19e-06	9.99e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA1—atherosclerosis	7.17e-06	9.97e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.55e-06	9.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—atherosclerosis	6.39e-06	8.88e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—atherosclerosis	6.32e-06	8.78e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—atherosclerosis	6.2e-06	8.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—atherosclerosis	5.81e-06	8.08e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—atherosclerosis	5.79e-06	8.05e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—atherosclerosis	5.68e-06	7.9e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—atherosclerosis	5.44e-06	7.55e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—atherosclerosis	5.36e-06	7.45e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—atherosclerosis	5.34e-06	7.43e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.97e-06	6.91e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—atherosclerosis	3.82e-06	5.31e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—atherosclerosis	2.5e-06	3.47e-05	CbGpPWpGaD
